Literature DB >> 32373990

Radiological role in the detection, diagnosis and monitoring for the coronavirus disease 2019 (COVID-19).

L Hu1, C Wang.   

Abstract

OBJECTIVE: Coronavirus disease 2019 (COVID-19) has officially been declared a pandemic by the World Health Organization (WHO). Radiological examinations, especially computed tomography (CT), play an important role in the fight against COVID-19. A comprehensive and timely review of radiological role in the fight against COVID-19 remains urgent and mandatory. Hence, the aim of this review is to summarize the radiological role in the fight against COVID-19. This review of current studies on COVID-19 provides insight into the radiological role in the detection, diagnosis, and monitoring for COVID-19. The typical radiological features of COVID-19 include bilateral, multifocal, and multilobar ground glass opacification with patchy consolidation, a peripheral/subpleural or posterior distribution (or both), mainly in the lower lobes. A combination of chest CT and repeat Reverse Transcription-Polymerase Chain Reaction (RT-PCR) testing may be beneficial for the diagnosis of COVID-19 in the setting of strongly clinical suspicion. Chest CT may improve the sensitivity for COVID-19 diagnosis, but patients' exposure to radiation should be kept as low as possible especially for children and pregnant women patients.

Entities:  

Mesh:

Year:  2020        PMID: 32373990     DOI: 10.26355/eurrev_202004_21035

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

Review 1.  COVID-19 or non-COVID viral pneumonia: How to differentiate based on the radiologic findings?

Authors:  Azadeh Eslambolchi; Ana Maliglig; Amit Gupta; Ali Gholamrezanezhad
Journal:  World J Radiol       Date:  2020-12-28

Review 2.  COVID-19, sex, and gender in China: a scoping review.

Authors:  Huiyun Feng; Connie Cai Ru Gan; Diego Leiva; Bao Ling Zhang; Sara E Davies
Journal:  Global Health       Date:  2022-02-04       Impact factor: 4.185

3.  Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.

Authors:  Kristoffer Grundtvig Skaarup; Mats Christian Højbjerg Lassen; Caroline Espersen; Jannie Nørgaard Lind; Niklas Dyrby Johansen; Morten Sengeløv; Alia Saed Alhakak; Anne Bjerg Nielsen; Kirstine Ravnkilde; Raphael Hauser; Liv Borum Schöps; Eva Holt; Henning Bundgaard; Christian Hassager; Reza Jabbari; Jørn Carlsen; Ole Kirk; Uffe Bodtger; Matias Greve Lindholm; Lothar Wiese; Ole Peter Kristiansen; Emil Schwarz Walsted; Olav Wendelboe Nielsen; Birgitte Lindegaard; Niels Tønder; Klaus Nielsen Jeschke; Charlotte Suppli Ulrik; Morten Lamberts; Pradeesh Sivapalan; Jannik Pallisgaard; Gunnar Gislason; Kasper Iversen; Jens Ulrik Stæhr Jensen; Morten Schou; Søren Helbo Skaarup; Elke Platz; Tor Biering-Sørensen
Journal:  J Ultrasound       Date:  2021-07-02

4.  Contrast enhanced ultrasound (CEUS) to assess pleural pulmonal changes in severe COVID-19 infection: First results.

Authors:  E M Jung; C Stroszczynski; F Jung
Journal:  Clin Hemorheol Microcirc       Date:  2020       Impact factor: 2.375

Review 5.  The Global Emergency of Novel Coronavirus (SARS-CoV-2): An Update of the Current Status and Forecasting.

Authors:  Hossein Hozhabri; Francesca Piceci Sparascio; Hamidreza Sohrabi; Leila Mousavifar; René Roy; Daniela Scribano; Alessandro De Luca; Cecilia Ambrosi; Meysam Sarshar
Journal:  Int J Environ Res Public Health       Date:  2020-08-05       Impact factor: 3.390

6.  Metastatic pulmonary dissemination as differential diagnosis of COVID-19 disease.

Authors:  Cristel Perdigón Martinelli; Carlos Morell; Carolina González; Cristina Nova-Lozano
Journal:  BMJ Case Rep       Date:  2020-10-07

7.  CT radiomic models to distinguish COVID-19 pneumonia from other interstitial pneumonias.

Authors:  Nicolò Cardobi; Giulio Benetti; Giuseppe Cardano; Cinzia Arena; Claudio Micheletto; Carlo Cavedon; Stefania Montemezzi
Journal:  Radiol Med       Date:  2021-05-27       Impact factor: 3.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.